Puma Biotechnology, Inc. (PBYI): Shares Outstanding

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2021-12-31, 2022-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

50.41M
As of 2025-12-31
51.10M
As of 2026-06-30
+2.8%
3-year compound annual growth
2010-12-31: 4.00M2011-12-31: 20.04M2012-12-31: 28.68M2013-12-31: 28.99M2014-12-31: 30.55M2015-12-31: 32.47M2016-12-31: 36.83M2017-12-31: 37.59M2018-12-31: 38.33M2019-12-31: 39.20M2020-12-31: 40.09M2021-12-31: 41.18M2022-12-31: 46.35M2023-12-31: 47.65M2024-12-31: 49.11M2025-12-31: 50.41M50.41M
2010-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3150.41M+2.7%2026-02-26, Balance as of period end
2024-12-3149.11M+3.1%2026-02-26, Balance as of period end
2023-12-3147.65M+2.8%2025-02-27, Balance as of period end
2022-12-3146.35Mn/c2024-02-29, Balance as of period end
2021-12-3141.18Mn/c2023-03-02, Balance as of period end
2020-12-3140.09M+2.3%2022-03-03, Balance as of period end
2019-12-3139.20M+2.3%2021-03-01, Balance as of period end
2018-12-3138.33M+1.9%2020-02-28, Balance as of period end
2017-12-3137.59M+2.1%2019-03-01, Balance as of period end
2016-12-3136.83M+13.4%2018-03-09, Balance as of period end
2015-12-3132.47M+6.3%2017-03-01, Balance as of period end
2014-12-3130.55M+5.4%2016-02-29, Balance as of period end
2013-12-3128.99M+1.1%2015-03-02, Balance as of period end
2012-12-3128.68Mn/c2014-03-03, Balance as of period end
2011-12-3120.04Mn/c2013-04-01, Balance as of period end
2010-12-314.00Mn/a2012-03-29, Balance as of period end